Skip to main content
Clinical Trials/NCT02466880
NCT02466880
Completed
Not Applicable

Intervention for Diabetes With Education, Advancement and Support (IDEAS) Study

Monash University1 site in 1 country240 target enrollmentApril 2015

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Diabetes Mellitus
Sponsor
Monash University
Enrollment
240
Locations
1
Primary Endpoint
Change in Hemoglobin A1c
Status
Completed
Last Updated
9 years ago

Overview

Brief Summary

This study aims to evaluate a culturally appropriate, low cost and sustainable management plan for patients with type 2 diabetes mellitus (T2DM). Various randomized controlled trials confirmed that T2DM can be delayed with lifestyle intervention and programmes which promote improvements in diet, increased physical activity and weight loss. Translation of lifestyle intervention to real-life settings however remains a major challenge.

The investigators therefore propose a diabetes management trial for T2DM patients using telemedicine. This project's innovations include the use of information technology to deliver messages to the physicians while similarly involving family members of diabetics to manage the patient's condition collectively. This creates a sense of well-being, empowering the individual as well as the community to be responsible for their own health and well-being

Registry
clinicaltrials.gov
Start Date
April 2015
End Date
February 28, 2017
Last Updated
9 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Shaun Lee Wen Huey

Senior Lecturer

Monash University

Eligibility Criteria

Inclusion Criteria

  • Type 2 diabetes diagnosed by a physician at least six months prior to study enrollment
  • HbA1c of \> 7.5% but less than 11.0% within the most recent 3 months
  • Access to internet and an e-mail address , or access to a smartphone with 3G services
  • Not pregnant or history of heart diseases, serious illness, cancer diagnosis or any other conditions that can impede participation

Exclusion Criteria

  • Unable or unwilling to give informed consent or communicate with local study staff
  • Current diagnosis of schizophrenia, other psychotic disorders, or bipolar disorder
  • Hospitalization for depression in past six months
  • Plans to relocate to an area or travel plans that do not permit full participation in the study
  • Lack of support from primary health care provider or family members
  • History of bariatric surgery, small bowel resection, or extensive bowel resection
  • Currently pregnant or nursing
  • Cancer: requiring treatment in the past five years, except for non-melanoma skin cancers or cancers that have clearly been cured or in the opinion of the investigator carry an excellent prognosis (e.g., Stage 1 cervical cancer)
  • Cardiovascular disease (heart attack or procedure within the past three months or participation in a cardiac rehabilitation program within last three months, stroke or history/treatment for transient ischemic attacks in the past three months, or documented history of pulmonary embolus in past six months)
  • Other medical, psychiatric, or behavioral factors that in the judgment of the Principal Investigator may interfere with study participation or the ability to follow the intervention protocol

Outcomes

Primary Outcomes

Change in Hemoglobin A1c

Time Frame: 3 months, 6 months, 12 months

Secondary Outcomes

  • Change in Weight(3 months, 6 months, 12 months)
  • Change in Cholesterol(3 months, 6 months, 12 months)
  • Cost effectiveness and cost utility(1 year)
  • Change in Quality of life - Measured with EQ5D(3 months, 6 months, 12 months)
  • Change in Blood pressure(3 months, 6 months, 12 months)

Study Sites (1)

Loading locations...

Similar Trials